These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25663537)

  • 21. Heavy chain diseases.
    Wahner-Roedler DL; Kyle RA
    Best Pract Res Clin Haematol; 2005; 18(4):729-46. PubMed ID: 16026747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extranodal marginal zone B cell lymphoma of the orbit in a patient with sarcoidosis: a case report.
    Richards NQ; Kidwell ED; Ramadan AM; Naab TJ
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):252-5. PubMed ID: 25363228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrapericardial and intrapleural administration of rituximab to a patient with marginal zone lymphoma.
    Boguradzki P; Drozd-Sokolowska JE; Wieczorek J; Kowalik R; Starczewska M; Krol M; Kobylecka M; Opolski G; Wiktor-Jedrzejczak W
    Acta Haematol; 2013; 130(3):169-71. PubMed ID: 23735747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
    Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
    J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intestinal non-Hodgkin lymphoma: "immunoproliferative small intestinal disease"].
    Mrabti H; Raiss G; Raissouni S; Tazi el M; Inghaouen H; El Ghissassi I; Errihani H
    Presse Med; 2011 Nov; 40(11):995-1000. PubMed ID: 21458210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas.
    Castelli R; Bergamaschini L; Deliliers GL
    Med Oncol; 2017 Dec; 35(2):15. PubMed ID: 29288421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I study of bendamustine, lenalidomide and rituximab in relapsed and refractory lymphomas.
    Cheson BD; Crawford J
    Br J Haematol; 2015 May; 169(4):528-33. PubMed ID: 25752751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphoma.
    Alderuccio JP; Lossos IS
    Expert Rev Hematol; 2023 May; 16(5):333-348. PubMed ID: 37086394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two tracheal BALT lymphoma patients successfully treated with chemotherapy including rituximab.
    Hiraishi Y; Iikura M; Kogure Y; Hirashima J; Izumi S; Sugiyama H
    Respir Investig; 2014 Mar; 52(2):144-6. PubMed ID: 24636271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recent progress in the treatment of malignant lymphoma].
    Ogura M
    Gan To Kagaku Ryoho; 2001 Sep; 28(9):1213-35. PubMed ID: 11579632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomes.
    Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Singh AD; Cooper BW; De Lima MJ; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
    Br J Haematol; 2016 May; 173(3):404-12. PubMed ID: 26953041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL).
    Rigacci L; Puccini B; Cortelazzo S; Gaidano G; Piccin A; D'Arco A; Freilone R; Storti S; Orciuolo E; Zinzani PL; Zaja F; Bongarzoni V; Balzarotti M; Rota-Scalabrini D; Patti C; Gobbi M; Carpaneto A; Liberati AM; Bosi A; Iannitto E
    Ann Hematol; 2012 Jul; 91(7):1013-22. PubMed ID: 22349722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bendamustine produces durable responses with an acceptable safety profile in patients with rituximab-refractory indolent non-Hodgkin lymphoma.
    Cheson BD; Friedberg JW; Kahl BS; Van der Jagt RH; Tremmel L
    Clin Lymphoma Myeloma Leuk; 2010 Dec; 10(6):452-7. PubMed ID: 21189660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
    Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
    Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
    Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rare case of small bowel intussusception.
    Murino A; Despott EJ; Hansmann A; Heath P; Fraser C
    Endoscopy; 2012; 44 Suppl 2 UCTN():E157-8. PubMed ID: 22622719
    [No Abstract]   [Full Text] [Related]  

  • 37. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
    Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
    Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma.
    Else M; Marín-Niebla A; de la Cruz F; Batty P; Ríos E; Dearden CE; Catovsky D; Matutes E
    Br J Haematol; 2012 Nov; 159(3):322-8. PubMed ID: 23016878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas.
    Rigacci L; Nassi L; Puccioni M; Mappa S; Polito E; Dal Pozzo S; Alterini R; Carrai V; Puccini B; Bosi A
    Ann Hematol; 2007 Aug; 86(8):565-8. PubMed ID: 17483948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ongoing monoclonal B-cell proliferation is not common in gastric B-cell lymphoma after combined radiochemotherapy.
    Alpen B; Kuse R; Parwaresch R; Müller-Hermelink HK; Stolte M; Neubauer A
    J Clin Oncol; 2004 Aug; 22(15):3039-45. PubMed ID: 15284253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.